In 2015–2017, 64.9% of the 72.2 million women aged 15–49 in the United States were currently using contraception. The most common contraceptive methods currently used were female sterilization (18.6%), oral contraceptive pill (12.6%), long-acting reversible contraceptives (LARCs) (10.3%), and male condom (8.7%).
That would mean more than 5 million women in UDA are on oral contraceptives.
E4 will further expand the MARKET OF ORAL CONTRACEPTIVES
AS IT IS SAFER.
All well informed /wealthy/well educated women will move to E4 ,OC of MAYNE is my view
as it is some thing that they use for long term and not just one dose. SO SAFETY PROFILE WILL BE V V IMPORTANT.
MAYNE/MITHRA /E4 OC is a MULTIBILLION DOLLAR product in USA alone.
WHAT HAPPENS WHEN IT IS APPROVED AND MARKETED FOR MENOPAUSE/POST MENOPAUSE?
Then MAYNE AND MITHRA WILL BE MERGING I THINK.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)